Genoscience Pharma extends its first clinical trial of GN561 in patients with ad
- This topic has 0 replies, 1 voice, and was last updated 5 years, 8 months ago by
.
Viewing 1 post (of 1 total)
-
Posts
-
Genoscience Pharma extends its first clinical trial of GN561 in patients with advanced liver cancers to France
Enrollment is open for patients with intrahepatic cholangiocarcinoma and hepatocarcinoma at Croix-Rousse Hospital in Lyon and at Saint-Joseph Hospital in Paris
https://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=278384
Viewing 1 post (of 1 total)
- The forum ‘Clinical Trials’ is closed to new topics and replies.